1. Home
  2. ONC vs NTR Comparison

ONC vs NTR Comparison

Compare ONC & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • NTR
  • Stock Information
  • Founded
  • ONC 2010
  • NTR 2017
  • Country
  • ONC Switzerland
  • NTR Canada
  • Employees
  • ONC N/A
  • NTR N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • NTR Agricultural Chemicals
  • Sector
  • ONC Health Care
  • NTR Industrials
  • Exchange
  • ONC Nasdaq
  • NTR Nasdaq
  • Market Cap
  • ONC 26.9B
  • NTR 25.5B
  • IPO Year
  • ONC N/A
  • NTR N/A
  • Fundamental
  • Price
  • ONC $247.08
  • NTR $60.96
  • Analyst Decision
  • ONC Strong Buy
  • NTR Hold
  • Analyst Count
  • ONC 7
  • NTR 15
  • Target Price
  • ONC $326.43
  • NTR $60.33
  • AVG Volume (30 Days)
  • ONC 314.8K
  • NTR 2.0M
  • Earning Date
  • ONC 08-06-2025
  • NTR 08-06-2025
  • Dividend Yield
  • ONC N/A
  • NTR 3.58%
  • EPS Growth
  • ONC N/A
  • NTR N/A
  • EPS
  • ONC N/A
  • NTR 1.06
  • Revenue
  • ONC $4,175,868,000.00
  • NTR $24,739,000,000.00
  • Revenue This Year
  • ONC $869.15
  • NTR $5.84
  • Revenue Next Year
  • ONC $19.07
  • NTR $2.49
  • P/E Ratio
  • ONC N/A
  • NTR $56.83
  • Revenue Growth
  • ONC 51.16
  • NTR N/A
  • 52 Week Low
  • ONC $141.31
  • NTR $43.70
  • 52 Week High
  • ONC $287.88
  • NTR $65.08
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • NTR 57.08
  • Support Level
  • ONC N/A
  • NTR $61.71
  • Resistance Level
  • ONC N/A
  • NTR $65.08
  • Average True Range (ATR)
  • ONC 0.00
  • NTR 1.23
  • MACD
  • ONC 0.00
  • NTR -0.04
  • Stochastic Oscillator
  • ONC 0.00
  • NTR 33.01

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients - nitrogen, potash, and phosphate - although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Share on Social Networks: